Thorkil Kastberg Christensen

Thorkil Kastberg Christensen (Chief Financial Officer, Novo A/S) was born on 24 August, 1947 and is a Danish citizen. He holds an MSc in Chemical Engineering and a BA in Finance. In 1978 he joined Novo Industri A/S where he held two director positions in the areas of Finance and Investor Relations. From 1987 to 1989 he was technical and general manager of the enzyme division’s South East Asia regional office in Malaysia. After the merger of Novo and Nordisk Gentofte in 1989 he moved to Singapore to head the start-up and development of Novo Nordisk’s affiliates in Asia. Having spent a total of 13 years in Asia, latest as CEO of Novo Nordisk China, he returned to Denmark in 2003 and became CFO in Novo A/S.

Thorkil Kastberg Christensen is member of the board of directors in BioMimetic Therapeutics Inc. (NASDAQ : BMTI), Executives' Global Network A/S, vice-chairman of the board of Danish Chinese Business Forum, and holds board and advisory board memberships at Copenhagen University and Rokilde University.